This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Other adrenoceptor agonists

Ephedrine hydrochloride - AAH Pharmaceuticals Ltd

A non-specific adrenoceptor agonist.

By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily


By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days

Ephedrine hydrochloride - Aguettant Ltd

A non-specific adrenoceptor agonist.

For reversible airway obstruction by mouth
Adult: 15–60 mg 3 times a day.

Nasal congestion, sinusitis affecting the maxillary antrum by intranasal administration
Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.

Ephedrine hydrochloride - Alliance Healthcare (Distribution) Ltd

A non-specific adrenoceptor agonist.

By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily

By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days

Ephedrine hydrochloride - DE Pharmaceuticals

A non-specific adrenoceptor agonist.

By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily

By intranasal administration for nasal congestion and sinusitis affecting the maxillary atrum
• Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
• Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.

Ephedrine hydrochloride - Hameln Pharmaceuticals

A non-specific adrenoceptor agonist.

By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily


By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days

Ephedrine hydrochloride - Martindale Pharmaceuticals Ltd

A non-specific adrenoceptor agonist.

By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily

By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days

Ephedrine hydrochloride - Medihealth (Northern) Ltd

A non-specific adrenoceptor agonist.

By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily

By intranasal administration for nasal congestion, sinusitis affecting the maxillary antrum
• Over 12 years: apply 1–2 drops up to four times per day in each nostril for a maximum of seven days

Ephedrine hydrochloride - Sigma Pharmaceuticals Plc

A non-specific adrenoceptor agonist.

For reversible airway obstruction by mouth
Adult: 15–60 mg 3 times a day.

Nasal congestion, sinusitis affecting the maxillary antrum by intranasal administration
Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.

Ephedrine hydrochloride - Wockhardt UK Ltd

A non-specific adrenoceptor agonist.

By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily

By intranasal administration for nasal congestion and sinusitis affecting the maxillary atrum
• Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
• Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.